The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
November 28th 2024
Rising health care costs and the complex nature of medication management have prompted PBMs to adopt AI tools to enhance patient outcomes, streamline claims processes, reduce waste, and design smarter, data-driven health plans.
Patient Advocates: Congress Intended for Tax Credits in Federal and State Marketplaces
January 27th 2015In a friend-of-the-court brief filed today with the U.S. Supreme Court in the case of King v. Burwell, leading groups fighting chronic disease provide scientific evidence of the grave consequences if millions of people nationwide were to lose the tax credits provided under the Affordable Care Act that provide the financial assistance they need to afford health coverage.
Read More
Hypercholesterolemia Treatment Granted FDA Priority Review
January 27th 2015Sanofi and Regeneron Pharmaceuticals recently announced that the FDA has accepted for priority review a Biologics License Application for their investigational drug, alirocumab, which is indicated for patients with hypercholesterolemia.
Read More
FDA Approves Iron Replacement Product for Dialysis Patients
January 27th 2015The FDA has approved Rockwell Medical's Triferic, an iron compound delivered during dialysis, as an iron replacement product to maintain hemoglobin in adult patients with hemodialysis-dependent chronic kidney disease.
Read More
NACDS Emphasizes Collaboration in Curbing Prescription Drug Diversion, Abuse
January 27th 2015Emphasizing the importance of promoting policies that improve patient outcomes and lead to healthier, safer communities, the National Association of Chain Drug Stores submitted a statement to the U.S. House Committee on Energy and Commerce Subcommittee on Health in lead-up to today's hearing titled "Examining Public Health Legislation to Help Patients and Local Communities."
Read More
New mHealth Tools Enable HIV Patients to Become 2.9 Times More Successful at Managing Disease
January 27th 2015mscripts and Avella Specialty Pharmacy have recently completed analyzing data demonstrating the effectiveness of mobile pharmacy apps in helping HIV patients better manage their disease through improved medication adherence. Results from this analysis show that HIV patients using a mobile app which provides refill reminders, dosage reminders and other prescription management functionality are 2.9 times more likely to be adherent.
Read More
APhA Announces Candidates for President-Elect, Trustees and Honorary President
January 27th 2015The American Pharmacists Association today announced the slate of candidates for its Board of Trustees, President-elect and Honorary President. The elections for these positions will be held March 27-May 25, 2015. Association members will have the opportunity to meet the candidates at the APhA Annual Meeting and Exposition in San Diego, March 27-30, 2015.
Read More
Statement by Ralph G. Neas, President and CEO, GPhA, Regarding 21st Century Cures Discussion Draft
January 27th 2015"The Generic Pharmaceutical Association (GPhA) is deeply disappointed in today's 21st Century Cures discussion draft. While we appreciate that it is a draft, in its current form, the bill would upset the important balance between creating competition and encouraging innovation in the pharmaceutical marketplace, putting savings at risk and limiting access to affordable medicines for millions of American patients.
Read More
High Cholesterol During Young Adulthood Raises Heart Disease Risk
January 26th 2015New research in the American Heart Association's journal Circulation shows that long-term exposure to elevated cholesterol substantially increases lifetime risk for heart disease. For every ten years you have even mildly elevated cholesterol between the ages of 35 and 55, your risk of heart disease may be increased by nearly 40 percent.
Read More
FDA Approves First Nexium Generic
January 26th 2015The FDA today approved Ivax Pharmaceuticals' esomeprazole magnesium delayed-release capsules, the first generic version of AstraZeneca's proton pump inhibitor Nexium, for the treatment of gastroesophageal reflux disease in patients aged >1 year.
Read More